https://medicaex.com/businesswire/caire-to-acquire-mgc-diagnostics-holdings-inc/ 2022-11-29T15:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/CAIRE_Inc._Logo-wYOfa4.jpeg https://medicaex.com/businesswire/nexgen-biobanking-opens-in-gwinnett-county-bringing-crucial-biospecimen-storage-infrastructure-to-georgias-life-science-industry-2/ 2022-11-29T15:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/CGHI_Logo-1_RGB-W_300dpi_28329-CgWAgw.jpeg https://medicaex.com/businesswire/nexgen-biobanking-opens-in-gwinnett-county-bringing-crucial-biospecimen-storage-infrastructure-to-georgias-life-science-industry/ 2022-11-29T15:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/CGHI_Logo-1_RGB-W_300dpi_28329-lZ5wdI.jpeg https://medicaex.com/businesswire/cubresa-announces-the-appointment-of-2-new-board-members/ 2022-11-29T15:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/cubresa_logo-qkouFc.jpeg https://medicaex.com/businesswire/gyros-protein-technologies-adds-gyrolab-biomarker-kits-to-expand-range-of-ready-to-use-kits-and-reagents/ 2022-11-29T15:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo_GPT_2016_150_dpi_small-JIJ34b.jpeg https://medicaex.com/businesswire/global-healthy-living-foundation-launches-free-tool-demonstrating-how-state-laws-protecting-patient-assistance-programs-impact-health-insurance-premiums/ 2022-11-29T15:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo_ghlf_businessWire_720-tQeJ45.jpeg https://medicaex.com/businesswire/tvardi-therapeutics-to-present-at-the-34th-annual-piper-sandler-healthcare-conference-2/ 2022-11-29T14:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/Tvardi-Master_Logo-wSEZqb.jpeg https://medicaex.com/businesswire/parkinsons-foundation-and-tag-bio-partner-to-accelerate-research-and-drive-insights-into-parkinsons-disease-3/ 2022-11-29T14:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/tagbio-logo-kePmb4.jpeg https://medicaex.com/businesswire/ribon-therapeutics-announces-acquisition-of-pre-clinical-cd38-program-by-boehringer-ingelheim-2/ 2022-11-29T14:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo1-zQVkSu.jpeg https://medicaex.com/businesswire/feops-ai-enabled-solution-changes-tavi-pre-procedural-decision-in-one-third-of-patients-associated-with-favorable-clinical-outcomes-2/ 2022-11-29T14:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/FEOPS_logo_transp_300dpi-4wDxn9.jpeg https://medicaex.com/businesswire/the-termeer-foundation-announces-application-for-the-class-of-2023-termeer-fellows-is-open-2/ 2022-11-29T14:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/Termeer_Horizontal_dight_blue-nyZDg9.jpeg https://medicaex.com/businesswire/medical-informatics-corp-raises-27-million-in-financing-to-help-hospitals-manage-staff-shortages-and-create-new-standard-of-data-driven-care/ 2022-11-29T14:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/MIC_logo-f9VQvC.jpeg https://medicaex.com/businesswire/parkinsons-foundation-and-tag-bio-partner-to-accelerate-research-and-drive-insights-into-parkinsons-disease-2/ 2022-11-29T14:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/tagbio-logo-yHigsh.jpeg https://medicaex.com/businesswire/experity-appoints-dr-benjamin-barlow-as-chief-medical-officer/ 2022-11-29T14:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/Ben_Barlow-RUNXDc.jpeg https://medicaex.com/businesswire/the-termeer-foundation-announces-application-for-the-class-of-2023-termeer-fellows-is-open/ 2022-11-29T14:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/Termeer_Horizontal_dight_blue-3nzIVU.jpeg https://medicaex.com/businesswire/zs-and-abacus-insights-partner-to-bring-innovative-data-and-analytics-to-health-plans/ 2022-11-29T14:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/ZS_Logo_RGB-aJwHZs.jpeg https://medicaex.com/businesswire/exo-announces-new-headquarters-to-accommodate-companys-growth/ 2022-11-29T14:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/EXO_LOGO_FullColor2BCharcoal_RGB-jcfWAg.jpeg https://medicaex.com/businesswire/bryn-pharma-strengthens-board-of-directors-with-appointments-of-commercial-veterans-sandy-loreaux-and-william-d-humphries-2/ 2022-11-29T14:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/Bryn_Corporate_V2_500x250-cYGStN.jpeg https://medicaex.com/businesswire/bostongene-to-present-at-the-2022-san-antonio-breast-cancer-symposium/ 2022-11-29T14:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/bostongene-logo-cNokz8.jpeg https://medicaex.com/businesswire/feops-ai-enabled-solution-changes-tavi-pre-procedural-decision-in-one-third-of-patients-associated-with-favorable-clinical-outcomes/ 2022-11-29T14:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/FEOPS_logo_transp_300dpi-ExTOFM.jpeg https://medicaex.com/businesswire/viz-ai-and-cercare-medical-partner-to-support-neurovascular-clinical-decision-making/ 2022-11-29T14:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/VerticalLogo_Whitebg-1cL02R.jpeg https://medicaex.com/businesswire/bryn-pharma-strengthens-board-of-directors-with-appointments-of-commercial-veterans-sandy-loreaux-and-william-d-humphries/ 2022-11-29T14:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/Bryn_Corporate_V2_500x250-Glk5qF.jpeg https://medicaex.com/businesswire/ksl-pulse-scientific-named-national-distributor-in-canada-for-first-of-its-kind-covid-19-flu-at-home-molecular-test/ 2022-11-29T14:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/Lucira_Test_CovidFlu_BusinessWire-FLwtcD.jpeg https://medicaex.com/businesswire/ribon-therapeutics-announces-acquisition-of-pre-clinical-cd38-program-by-boehringer-ingelheim/ 2022-11-29T14:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo1-dmW56n.jpeg https://medicaex.com/businesswire/european-commission-grants-expanded-marketing-authorization-for-gileads-biktarvy-for-the-treatment-of-hiv-in-pediatric-populations/ 2022-11-29T14:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/GCP_Primarylarge_1-l2JJhP.jpeg https://medicaex.com/businesswire/tvardi-therapeutics-to-present-at-the-34th-annual-piper-sandler-healthcare-conference/ 2022-11-29T14:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/Tvardi-Master_Logo-DwtvqR.jpeg https://medicaex.com/businesswire/illinois-hiv-care-connect-presents-personal-stories-of-healthy-aging-with-hiv/ 2022-11-29T14:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/HIV2BAging_Final_IG_1080x1080-5uDixL.jpeg https://medicaex.com/businesswire/parkinsons-foundation-and-tag-bio-partner-to-accelerate-research-and-drive-insights-into-parkinsons-disease/ 2022-11-29T14:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/tagbio-logo-VTcdye.jpeg https://medicaex.com/businesswire/microbiotica-announces-transition-of-leadership-2/ 2022-11-29T13:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/microbiotica-logo-vL0AXA.jpeg https://medicaex.com/businesswire/gate-neurosciences-doses-first-subject-in-a-translational-eeg-biomarker-study-of-apimostinel-a-rapid-acting-treatment-for-acute-depressive-disorders-2/ 2022-11-29T13:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/Gate_Logo-dOLoZv.jpeg https://medicaex.com/businesswire/bighat-biosciences-announces-research-collaboration-with-merck-2/ 2022-11-29T13:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/Flat-Color-Vertical-Logo-Horizontal_28529-GLjGgH.jpeg https://medicaex.com/businesswire/healthlink-advisors-expands-managed-services-capabilities-3/ 2022-11-29T13:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/HLA_-_Square_Avatar_006_28129-L8IfHs.jpeg https://medicaex.com/businesswire/nanovibronix-announces-2-4-million-registered-direct-offering-priced-at-the-market-under-nasdaq-rules-3/ 2022-11-29T13:12:12+00:00 https://medicaex.com/businesswire/healthlink-advisors-expands-managed-services-capabilities-2/ 2022-11-29T13:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/HLA_-_Square_Avatar_006_28129-o5Zs7C.jpeg https://medicaex.com/businesswire/planet-dds-selected-by-interdent-as-new-dental-software-provider/ 2022-11-29T13:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/01_Planet_DDS-Main_Logo-2_Color-RGB-Pn1CaG.jpeg https://medicaex.com/businesswire/nanovibronix-announces-2-4-million-registered-direct-offering-priced-at-the-market-under-nasdaq-rules-2/ 2022-11-29T13:12:09+00:00 https://medicaex.com/businesswire/healthcare-erp-consulting-services-global-market-report-2022-growing-healthcare-expenditure-and-rising-adoption-levels-of-advanced-technological-solutions-drives-sector-researchandmarkets-com/ 2022-11-29T13:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-w9WsoP.jpeg https://medicaex.com/businesswire/bighat-biosciences-announces-research-collaboration-with-merck/ 2022-11-29T13:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/Flat-Color-Vertical-Logo-Horizontal_28529-TPJ0Lr.jpeg https://medicaex.com/businesswire/2022-emerging-medical-technologies-spotlight-tool-updated-monthly-with-1855-companies-researchandmarkets-com/ 2022-11-29T13:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-vSrVDu.jpeg https://medicaex.com/businesswire/t-heart-appoints-sarah-sorrel-as-independent-board-member/ 2022-11-29T13:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/Sarah_Sorrel-d5eRtK.jpeg https://medicaex.com/businesswire/novocures-optune-approved-in-canada-for-the-treatment-of-newly-diagnosed-and-recurrent-glioblastoma/ 2022-11-29T13:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/novocure_main405x-quTGqq.jpeg https://medicaex.com/businesswire/nanovibronix-announces-2-4-million-registered-direct-offering-priced-at-the-market-under-nasdaq-rules/ 2022-11-29T13:12:06+00:00 https://medicaex.com/businesswire/healthcare-under-cyberattack-unprotected-medical-iot-devices-threaten-patient-care/ 2022-11-29T13:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/cap_logo_full_color_rgb-OFejCt.jpeg https://medicaex.com/businesswire/gate-neurosciences-doses-first-subject-in-a-translational-eeg-biomarker-study-of-apimostinel-a-rapid-acting-treatment-for-acute-depressive-disorders/ 2022-11-29T13:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/Gate_Logo-gSgfCY.jpeg https://medicaex.com/businesswire/healthlink-advisors-expands-managed-services-capabilities/ 2022-11-29T13:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/HLA_-_Square_Avatar_006_28129-WCUnLM.jpeg https://medicaex.com/businesswire/rallybio-to-present-at-the-jmp-securities-hematology-and-oncology-summit/ 2022-11-29T13:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/Press_Release_Logo-qjsT9C.jpeg https://medicaex.com/businesswire/aldeyra-therapeutics-submits-new-drug-application-to-the-u-s-food-and-drug-administration-for-reproxalap-for-the-treatment-of-signs-and-symptoms-of-dry-eye-disease/ 2022-11-29T13:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/ALDX_logo_JPEG-psz0dR.jpeg https://medicaex.com/businesswire/microbiotica-announces-transition-of-leadership/ 2022-11-29T13:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/microbiotica-logo-CWVNRp.jpeg https://medicaex.com/businesswire/inversago-pharma-doses-first-patient-in-phase-2-trial-of-inv-202-an-oral-peripherally-acting-cb1-inverse-agonist-in-patients-with-diabetic-kidney-disease-2/ 2022-11-29T12:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/Inversago_RGB-t47Vok.jpeg https://medicaex.com/businesswire/adicet-bio-appoints-nancy-boman-m-d-ph-d-as-senior-vice-president-and-chief-regulatory-officer-2/ 2022-11-29T12:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/adicet_logo_500x300_2800229_2800429-GfVspZ.jpeg https://medicaex.com/businesswire/virios-therapeutics-inc-to-present-at-the-virtual-planet-microcap-showcase-2/ 2022-11-29T12:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/Virios_Logo_Blue-NigEiO.jpeg https://medicaex.com/businesswire/cajal-neuroscience-launches-with-96-million-to-transform-target-and-drug-discovery-in-neurodegeneration-2/ 2022-11-29T12:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/Cajal_Neuroscience-logo-NLCa1f.jpeg https://medicaex.com/businesswire/mispro-to-open-contract-vivarium-in-bostons-seaport-2/ 2022-11-29T12:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/Mispro_logos_PrimaryMark_RGB-9cxHYj.jpeg https://medicaex.com/businesswire/europe-medical-device-security-market-grow-by-9-8-annually-through-2031-researchandmarkets-com/ 2022-11-29T12:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-UKUzmV.jpeg https://medicaex.com/businesswire/catheter-precisions-vivo-systems-used-in-more-than-20-procedures-at-nyu-langone-hospital/ 2022-11-29T12:12:09+00:00 https://medicaex.com/businesswire/cajal-neuroscience-launches-with-96-million-to-transform-target-and-drug-discovery-in-neurodegeneration/ 2022-11-29T12:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/Cajal_Neuroscience-logo-xq9lPv.jpeg https://medicaex.com/businesswire/mispro-to-open-contract-vivarium-in-bostons-seaport/ 2022-11-29T12:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/Mispro_logos_PrimaryMark_RGB-oaMGFh.jpeg https://medicaex.com/businesswire/inversago-pharma-doses-first-patient-in-phase-2-trial-of-inv-202-an-oral-peripherally-acting-cb1-inverse-agonist-in-patients-with-diabetic-kidney-disease/ 2022-11-29T12:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/Inversago_RGB-kkx6N8.jpeg https://medicaex.com/businesswire/adicet-bio-appoints-nancy-boman-m-d-ph-d-as-senior-vice-president-and-chief-regulatory-officer/ 2022-11-29T12:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/adicet_logo_500x300_2800229_2800429-65PVCf.jpeg https://medicaex.com/businesswire/virios-therapeutics-inc-to-present-at-the-virtual-planet-microcap-showcase/ 2022-11-29T12:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/Virios_Logo_Blue-QYHBmh.jpeg https://medicaex.com/businesswire/mednow-achieves-record-q4-2022-financial-results-with-11-q-q-revenue-growth-and-5700-y-y-revenue-growth/ 2022-11-29T12:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/Mednow_Primary_Horizontal_Logo_5BIcon_2B_Wordmark5D_RGB-wzgEdM.jpeg https://medicaex.com/businesswire/turnstone-biologics-enters-cooperative-research-and-development-agreement-with-the-national-cancer-institute-to-study-til-therapy-in-combination-with-viral-immunotherapy-2/ 2022-11-29T11:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/TSTN_Logo_Twitter-a5iOyv.jpeg https://medicaex.com/businesswire/global-artificial-intelligence-in-healthcare-market-report-2022-increase-in-processing-power-of-ai-systems-leads-to-enhanced-ai-capabilities-researchandmarkets-com/ 2022-11-29T11:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-Ioz8Fq.jpeg https://medicaex.com/businesswire/bgi-preparing-to-launch-improved-non-invasive-colorectal-cancer-screening-test-colotect-3-0-2/ 2022-11-29T11:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/BGI_LOGO-Ogrm8P.jpeg https://medicaex.com/businesswire/bgi-preparing-to-launch-improved-non-invasive-colorectal-cancer-screening-test-colotect-3-0/ 2022-11-29T11:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/BGI_LOGO-l0Qfzz.jpeg https://medicaex.com/businesswire/global-super-absorbent-dressings-market-report-2022-to-2030-players-include-3m-coloplast-hartmann-usa-and-molnlycke-health-care-researchandmarkets-com/ 2022-11-29T11:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-e8t0F1.jpeg https://medicaex.com/businesswire/vizient-announces-agreement-with-safesource-direct-for-american-made-exam-gloves/ 2022-11-29T11:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/Vizient_Logo_V2-kmz5K2.jpeg https://medicaex.com/businesswire/kaneka-to-manufacture-and-supply-intermediates-for-shionogi-covid-19-drug/ 2022-11-29T11:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/KANEKA-uWA3i1.jpeg https://medicaex.com/businesswire/turnstone-biologics-enters-cooperative-research-and-development-agreement-with-the-national-cancer-institute-to-study-til-therapy-in-combination-with-viral-immunotherapy/ 2022-11-29T11:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/TSTN_Logo_Twitter-fWEjof.jpeg https://medicaex.com/businesswire/new-funding-of-2-million-for-research-bringing-us-one-step-closer-to-a-cure-for-follicular-lymphoma/ 2022-11-29T10:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/52984259_-_4795198c_-_FLF_-_Replacement_Logo-wTFpal.jpeg https://medicaex.com/businesswire/astrazeneca-to-acquire-neogene-therapeutics-accelerating-ambition-in-oncology-cell-therapy-2/ 2022-11-29T07:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/Neogene_Logo-z1bGRP.jpeg https://medicaex.com/businesswire/netris-pharma-doses-first-patient-in-phase-2-study-of-np137-for-checkpoint-inhibitor-resistance-2/ 2022-11-29T07:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/Netris_Logo-SFbemb.jpeg https://medicaex.com/businesswire/genomic-visions-cutting-edge-telosizer-application-to-be-used-in-cancer-research-2/ 2022-11-29T07:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/2012_09_logo_genomicvision_def-wHBAAP.jpeg https://medicaex.com/businesswire/genomic-visions-cutting-edge-telosizer-application-to-be-used-in-cancer-research/ 2022-11-29T07:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/2012_09_logo_genomicvision_def-N1Ark2.jpeg https://medicaex.com/businesswire/astrazeneca-to-acquire-neogene-therapeutics-accelerating-ambition-in-oncology-cell-therapy/ 2022-11-29T07:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/Neogene_Logo-cg0eLk.jpeg https://medicaex.com/businesswire/netris-pharma-doses-first-patient-in-phase-2-study-of-np137-for-checkpoint-inhibitor-resistance/ 2022-11-29T07:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/Netris_Logo-G4VKTz.jpeg https://medicaex.com/businesswire/sonic-healthcare-acquires-strategic-stake-in-microba-life-sciences-establishes-significant-commercial-partnership-3/ 2022-11-29T05:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/Microba-Life-Sciences-Microbiome-Testing-Services-5eMeFs.jpeg https://medicaex.com/businesswire/sonic-healthcare-acquires-strategic-stake-in-microba-life-sciences-establishes-significant-commercial-partnership-2/ 2022-11-29T05:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/Microba-Life-Sciences-Microbiome-Testing-Services-xVlFc1.jpeg https://medicaex.com/businesswire/sonic-healthcare-acquires-strategic-stake-in-microba-life-sciences-establishes-significant-commercial-partnership/ 2022-11-29T05:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/Microba-Life-Sciences-Microbiome-Testing-Services-jlqYnE.jpeg https://medicaex.com/businesswire/touchlight-receives-grant-to-advance-rapid-scalable-and-thermostable-doggybone-dna-vaccine-platform-3/ 2022-11-29T00:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/Touchlight_logo-8WfAws.jpeg https://medicaex.com/businesswire/touchlight-receives-grant-to-advance-rapid-scalable-and-thermostable-doggybone-dna-vaccine-platform-2/ 2022-11-29T00:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/Touchlight_logo-oCNPQH.jpeg https://medicaex.com/businesswire/touchlight-receives-grant-to-advance-rapid-scalable-and-thermostable-doggybone-dna-vaccine-platform/ 2022-11-29T00:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/Touchlight_logo-noHbbA.jpeg https://medicaex.com/businesswire/mediview-and-ge-healthcare-to-bring-augmented-reality-solutions-to-medical-imaging-for-the-interventional-space-4/ 2022-11-28T23:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/RSNA_2022_OmnifyXR_Interventional_Suite-brHdbr.jpeg https://medicaex.com/businesswire/mediview-and-ge-healthcare-to-bring-augmented-reality-solutions-to-medical-imaging-for-the-interventional-space-3/ 2022-11-28T23:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/RSNA_2022_OmnifyXR_Interventional_Suite-VrsDhL.jpeg https://medicaex.com/businesswire/mediview-and-ge-healthcare-to-bring-augmented-reality-solutions-to-medical-imaging-for-the-interventional-space-2/ 2022-11-28T23:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/RSNA_2022_OmnifyXR_Interventional_Suite-IjxOos.jpeg https://medicaex.com/businesswire/mediview-and-ge-healthcare-to-bring-augmented-reality-solutions-to-medical-imaging-for-the-interventional-space/ 2022-11-28T23:12:02+00:00 https://medicaex.com/wp-content/uploads/2022/11/RSNA_2022_OmnifyXR_Interventional_Suite-Y7skuK.jpeg https://medicaex.com/businesswire/alpha-cognition-announces-third-quarter-2022-results-and-provides-corporate-update-2/ 2022-11-28T22:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/Alpha_Cognition_Inc._-_Logo_Left_Side2C_Dark_Colour-moo87T.jpeg https://medicaex.com/businesswire/fsd-pharma-announces-changes-to-the-board-of-directors-2/ 2022-11-28T22:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/400x400_FSD-31Zwop.jpeg https://medicaex.com/businesswire/bruce-ragsdale-to-join-ichor-as-chief-operating-officer/ 2022-11-28T22:12:05+00:00 https://medicaex.com/businesswire/alpha-cognition-announces-third-quarter-2022-results-and-provides-corporate-update/ 2022-11-28T22:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/Alpha_Cognition_Inc._-_Logo_Left_Side2C_Dark_Colour-TE40Qd.jpeg https://medicaex.com/businesswire/fsd-pharma-announces-changes-to-the-board-of-directors/ 2022-11-28T22:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/400x400_FSD-2kSGfp.jpeg https://medicaex.com/businesswire/cimeio-therapeutics-announces-issuance-of-key-patent-covering-cell-therapy-platform-2/ 2022-11-28T21:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/Cimeio_logo-N5m720.jpeg https://medicaex.com/businesswire/arrowhead-pharmaceuticals-reports-fiscal-2022-year-end-results-2/ 2022-11-28T21:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/ah_logo_cmyk-w012vC.jpeg https://medicaex.com/businesswire/nanovibronix-receives-fda-510k-premarket-clearance-for-painshield-plus-2/ 2022-11-28T21:12:13+00:00 https://medicaex.com/businesswire/nanovibronix-receives-fda-510k-premarket-clearance-for-painshield-plus/ 2022-11-28T21:12:10+00:00 https://medicaex.com/businesswire/arrowhead-pharmaceuticals-reports-fiscal-2022-year-end-results/ 2022-11-28T21:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/ah_logo_cmyk-XB7Edd.jpeg https://medicaex.com/businesswire/cimeio-therapeutics-announces-issuance-of-key-patent-covering-cell-therapy-platform/ 2022-11-28T21:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/Cimeio_logo-HgPFIS.jpeg https://medicaex.com/businesswire/organabio-to-exhibit-at-2022-ash-annual-meeting-and-exposition/ 2022-11-28T19:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/ASH22_LI-ypPtWV.jpeg https://medicaex.com/businesswire/siemens-healthineers-atrium-health-enter-multi-year-value-partnership-to-improve-health-care-capabilities-access-and-equity-3/ 2022-11-28T19:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/sh_logo_rgb-weRLzf.jpeg https://medicaex.com/businesswire/siemens-healthineers-atrium-health-enter-multi-year-value-partnership-to-improve-health-care-capabilities-access-and-equity-2/ 2022-11-28T19:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/sh_logo_rgb-FIJFPM.jpeg https://medicaex.com/businesswire/siemens-healthineers-atrium-health-enter-multi-year-value-partnership-to-improve-health-care-capabilities-access-and-equity/ 2022-11-28T19:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/sh_logo_rgb-Q9FYIJ.jpeg https://medicaex.com/businesswire/neuromodulation-devices-markets-2029-researchandmarkets-com-2/ 2022-11-28T16:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-E04sPb.jpeg https://medicaex.com/businesswire/global-microbiome-therapeutics-market-report-2022-mergers-and-collaborations-continue-to-boost-brand-new-industry-researchandmarkets-com/ 2022-11-28T16:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-iKd6ii.jpeg https://medicaex.com/businesswire/croma-australia-pty-ltd-a-subsidiary-of-hugel-aesthetics-receives-tga-approval-in-australia-for-letybo-letibotulinumtoxina-for-the-treatment-of-glabellar-lines/ 2022-11-28T16:12:11+00:00 https://medicaex.com/businesswire/neurologica-announces-fda-510k-clearance-of-bodytom-64-3/ 2022-11-28T16:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/BodyTom_64_withShadow_brighter-cx9P5t.jpeg https://medicaex.com/businesswire/neurologica-announces-fda-510k-clearance-of-bodytom-64-2/ 2022-11-28T16:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/BodyTom_64_withShadow_brighter-S9edAM.jpeg https://medicaex.com/businesswire/neuromodulation-devices-markets-2029-researchandmarkets-com/ 2022-11-28T16:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-8Oy2IZ.jpeg https://medicaex.com/businesswire/neurologica-announces-fda-510k-clearance-of-bodytom-64/ 2022-11-28T16:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/BodyTom_64_withShadow_brighter-z3JnGq.jpeg https://medicaex.com/businesswire/infusion-pump-global-market-report-2022-rising-demand-for-ambulatory-infusion-pumps-in-home-care-settings-fuels-growth-researchandmarkets-com/ 2022-11-28T16:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-E6S6jf.jpeg https://medicaex.com/businesswire/2022-worldwide-psoriatic-arthritis-treatment-industry-epidemiology-pipeline-analysis-report-by-drug-class-gender-type-disease-type-age-group-severity-type-and-geography-researchandmarket/ 2022-11-28T16:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-iwkSgt.jpeg https://medicaex.com/businesswire/biocytogen-enters-into-antibody-agreement-with-adc-therapeutics-4/ 2022-11-28T15:12:17+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo250-t2EouV.jpeg https://medicaex.com/businesswire/global-epigenetics-market-analysis-forecasts-report-2016-2021-2021-2026f-2031f-featuring-major-players-illumina-thermo-fisher-scientific-merck-millipore-abcam-active-motif-resea/ 2022-11-28T15:12:17+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-64ARKc.jpeg https://medicaex.com/businesswire/synaps-dx-honors-caregivers-patients-and-families-during-caregivers-and-alzheimers-awareness-months-2/ 2022-11-28T15:12:17+00:00 https://medicaex.com/wp-content/uploads/2022/11/SYNAPS_DX_LOGO_COLOR_HORIZONTAL-nhmgJW.jpeg https://medicaex.com/businesswire/global-cancer-tumor-profiling-market-report-2022-growing-preference-for-personalized-medicine-presents-opportunities-researchandmarkets-com-2/ 2022-11-28T15:12:16+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-Cwwu8v.jpeg https://medicaex.com/businesswire/pfizer-invites-public-to-view-and-listen-to-webcast-of-pfizer-discussion-at-healthcare-conference-4/ 2022-11-28T15:12:16+00:00 https://medicaex.com/wp-content/uploads/2022/11/Pfizer_Logo_Color_RGB_APPROVED-Bss9DW.jpeg https://medicaex.com/businesswire/4d-imaging-in-healthcare-global-market-report-2022-greater-incidence-of-coronary-artery-disease-boosts-sector-growth-researchandmarkets-com/ 2022-11-28T15:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-G5vGBo.jpeg https://medicaex.com/businesswire/tops-launches-integrated-payments-processing-for-orthodontists-with-topspay/ 2022-11-28T15:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/Tops_Profile_Picture401x-bBjEGs.jpeg https://medicaex.com/businesswire/medimaps-group-appoints-meinhard-f-schmidt-as-board-chairman-adds-anne-le-grand-and-five-additional-board-members-4/ 2022-11-28T15:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/BOD_PHOTOS-Pu8joJ.jpeg https://medicaex.com/businesswire/instinct-announces-growth-equity-investment-from-mainsail-partners/ 2022-11-28T15:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/Instinct-Logo-Navy-Company-2_4x_28129_2800229-AsXukV.jpeg https://medicaex.com/businesswire/synaps-dx-honors-caregivers-patients-and-families-during-caregivers-and-alzheimers-awareness-months/ 2022-11-28T15:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/SYNAPS_DX_LOGO_COLOR_HORIZONTAL-7mpvu5.jpeg https://medicaex.com/businesswire/medimaps-group-appoints-meinhard-f-schmidt-as-board-chairman-adds-anne-le-grand-and-five-additional-board-members-3/ 2022-11-28T15:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/BOD_PHOTOS-mdZ8KF.jpeg https://medicaex.com/businesswire/medimaps-group-appoints-meinhard-f-schmidt-as-board-chairman-adds-anne-le-grand-and-five-additional-board-members-2/ 2022-11-28T15:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/BOD_PHOTOS-VX6SgO.jpeg https://medicaex.com/businesswire/pfizer-invites-public-to-view-and-listen-to-webcast-of-pfizer-discussion-at-healthcare-conference-3/ 2022-11-28T15:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/Pfizer_Logo_Color_RGB_APPROVED-bneIPi.jpeg https://medicaex.com/businesswire/biocytogen-enters-into-antibody-agreement-with-adc-therapeutics-3/ 2022-11-28T15:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo250-YDmfi3.jpeg https://medicaex.com/businesswire/worldwide-spatial-biology-market-forecasted-to-grow-at-30-p-a-reaching-1-2b-by-2027-market-report-by-decibio-consulting/ 2022-11-28T15:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/Decibio-wordmark-black_28129-PBGaX6.jpeg https://medicaex.com/businesswire/medimaps-group-appoints-meinhard-f-schmidt-as-board-chairman-adds-anne-le-grand-and-five-additional-board-members/ 2022-11-28T15:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/BOD_PHOTOS-wl16Ai.jpeg https://medicaex.com/businesswire/global-cancer-tumor-profiling-market-report-2022-growing-preference-for-personalized-medicine-presents-opportunities-researchandmarkets-com/ 2022-11-28T15:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-9ypArC.jpeg https://medicaex.com/businesswire/gilead-and-arcus-biosciences-announce-positive-update-on-joint-tigit-program-from-interim-analysis-of-arc-7-study-in-non-small-cell-lung-cancer/ 2022-11-28T14:12:16+00:00 https://medicaex.com/wp-content/uploads/2022/11/GCP_Primarylarge_1-yvWbk0.jpeg https://medicaex.com/businesswire/therapeutic-solutions-international-granted-broad-patent-on-treatment-of-neurodegenerative-conditions-2/ 2022-11-28T14:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo_tsoi-doRyZz.jpeg https://medicaex.com/businesswire/navidea-biopharmaceuticals-announces-50th-participant-enrolled-in-the-companys-phase-3-trial-in-rheumatoid-arthritis/ 2022-11-28T14:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/navidea_cmyk-ExY0xq.jpeg https://medicaex.com/businesswire/a-novel-azapeptide-editing-method-provides-potential-for-new-drug-development-feinstein-institutes-research-shows-2/ 2022-11-28T14:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/Yousef_Al_Abed_PhD-b75Wxc.jpeg https://medicaex.com/businesswire/bionaut-labs-closes-43m-in-series-b-led-by-khosla-ventures-to-advance-first-in-class-micro-robotic-technology-and-remove-barriers-to-treat-rare-and-debilitating-diseases-3/ 2022-11-28T14:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-bionaut403x_28129-Ml75Ig.jpeg https://medicaex.com/businesswire/blackford-announces-partnership-with-bialogics-to-accelerate-the-use-of-diagnostic-imaging-data-for-ai-driven-intelligence-2/ 2022-11-28T14:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/BlackfordAnalysisLogo-mrjmXl.jpeg https://medicaex.com/businesswire/blackford-announces-partnership-with-bialogics-to-accelerate-the-use-of-diagnostic-imaging-data-for-ai-driven-intelligence/ 2022-11-28T14:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/BlackfordAnalysisLogo-otgzmx.jpeg https://medicaex.com/businesswire/bionaut-labs-closes-43m-in-series-b-led-by-khosla-ventures-to-advance-first-in-class-micro-robotic-technology-and-remove-barriers-to-treat-rare-and-debilitating-diseases-2/ 2022-11-28T14:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-bionaut403x_28129-MjdiJi.jpeg https://medicaex.com/businesswire/key-life-sciences-stakeholders-launch-representative-term-sheet/ 2022-11-28T14:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/WSGR_logo-NY81Jb.jpeg https://medicaex.com/businesswire/carestream-health-unveils-new-x-ray-detectors-enhanced-x-ray-rooms-at-worlds-largest-radiology-exhibition/ 2022-11-28T14:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/Carestream_Logo-SESRrE.jpeg https://medicaex.com/businesswire/holiday-season-can-be-a-dangerous-time-for-drug-related-deaths/ 2022-11-28T14:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/ZIMHI_Photo-x51TdU.jpeg https://medicaex.com/businesswire/medcase-ntt-data-sign-a-definitive-agreement-to-enable-healthcare-ai-developers-a-holistic-solution-to-access-annotate-and-label-critical-imaging-data/ 2022-11-28T14:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/Medcase_Logo_Hi-Res-kE1o2J.jpeg https://medicaex.com/businesswire/bionaut-labs-closes-43m-in-series-b-led-by-khosla-ventures-to-advance-first-in-class-micro-robotic-technology-and-remove-barriers-to-treat-rare-and-debilitating-diseases/ 2022-11-28T14:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-bionaut403x_28129-PFAtAx.jpeg https://medicaex.com/businesswire/therapeutic-solutions-international-granted-broad-patent-on-treatment-of-neurodegenerative-conditions/ 2022-11-28T14:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo_tsoi-fUghD2.jpeg https://medicaex.com/businesswire/a-novel-azapeptide-editing-method-provides-potential-for-new-drug-development-feinstein-institutes-research-shows/ 2022-11-28T14:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/Yousef_Al_Abed_PhD-K7zaDd.jpeg https://medicaex.com/businesswire/lineage-announces-launch-of-phase-2a-study-by-genentech-of-rg6501-opregen-in-patients-with-geographic-atrophy-secondary-to-age-related-macular-degeneration-2/ 2022-11-28T13:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/LINEAGE_SCREEN_JPEG_1800x360-MDoyLF.jpeg https://medicaex.com/businesswire/viz-ai-appoints-radiology-advisory-board-to-advance-innovation-4/ 2022-11-28T13:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/VerticalLogo_Whitebg-agb7JB.jpeg https://medicaex.com/businesswire/charles-river-laboratories-opens-contract-vivarium-space-in-chicago-enhancing-access-to-aaalac-accredited-turnkey-research-program-3/ 2022-11-28T13:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/charles_river_logo-JzvoB9.jpeg https://medicaex.com/businesswire/strand-therapeutics-announces-series-a1-bringing-total-round-to-us97-million-2/ 2022-11-28T13:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/Nov_15_2022_-_Strand_-_0152_28229-xJDtvw.jpeg https://medicaex.com/businesswire/flywheel-building-federated-data-platform-for-development-of-unbiased-breast-imaging-ai-2/ 2022-11-28T13:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logotype_blk_-_new-hR2Vaq.jpeg https://medicaex.com/businesswire/perspectum-and-nuance-collaborate-to-scale-access-to-ai-enabled-integrated-digital-care-platforms-to-improve-patient-care-for-metabolic-disease/ 2022-11-28T13:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/MRCP_-_Perspectum_V2_28129_28129-lXPY63.jpeg https://medicaex.com/businesswire/viz-ai-launches-ai-powered-viz-radiology-suite-2/ 2022-11-28T13:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/Viz_Radiology_Suite_28129-lIZJjM.jpeg https://medicaex.com/businesswire/viz-ai-appoints-radiology-advisory-board-to-advance-innovation-3/ 2022-11-28T13:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/VerticalLogo_Whitebg-mHYbbj.jpeg https://medicaex.com/businesswire/flywheel-building-federated-data-platform-for-development-of-unbiased-breast-imaging-ai/ 2022-11-28T13:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logotype_blk_-_new-cYxzG9.jpeg https://medicaex.com/businesswire/outset-medical-to-present-at-the-bofa-securities-home-care-conference-2/ 2022-11-28T13:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/Outset-ID-OrangeGrey-U11so4.jpeg https://medicaex.com/businesswire/global-companion-diagnostic-tests-in-oncology-market-report-2022-accelerating-demand-for-targeted-cancer-treatment-tailored-drugs-drives-growth-researchandmarkets-com/ 2022-11-28T13:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-JEqpHH.jpeg https://medicaex.com/businesswire/charles-river-laboratories-opens-contract-vivarium-space-in-chicago-enhancing-access-to-aaalac-accredited-turnkey-research-program-2/ 2022-11-28T13:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/charles_river_logo-UxijDm.jpeg https://medicaex.com/businesswire/outset-medical-to-present-at-the-bofa-securities-home-care-conference/ 2022-11-28T13:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/Outset-ID-OrangeGrey-8jwOSv.jpeg https://medicaex.com/businesswire/viz-ai-launches-ai-powered-viz-radiology-suite/ 2022-11-28T13:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/Viz_Radiology_Suite_28129-fjFBrS.jpeg https://medicaex.com/businesswire/viz-ai-appoints-radiology-advisory-board-to-advance-innovation-2/ 2022-11-28T13:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/VerticalLogo_Whitebg-bZ9cOk.jpeg https://medicaex.com/businesswire/icpo-foundation-and-premit-enter-strategic-partnership-to-develop-a-network-of-precision-oncology-and-theranostic-centers/ 2022-11-28T13:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/ICPO_Logo_GROSS-M4QV6g.jpeg https://medicaex.com/businesswire/lineage-announces-launch-of-phase-2a-study-by-genentech-of-rg6501-opregen-in-patients-with-geographic-atrophy-secondary-to-age-related-macular-degeneration/ 2022-11-28T13:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/LINEAGE_SCREEN_JPEG_1800x360-8J7KIN.jpeg https://medicaex.com/businesswire/viz-ai-appoints-radiology-advisory-board-to-advance-innovation/ 2022-11-28T13:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/VerticalLogo_Whitebg-yjJs8n.jpeg https://medicaex.com/businesswire/strand-therapeutics-announces-series-a1-bringing-total-round-to-us97-million/ 2022-11-28T13:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/Nov_15_2022_-_Strand_-_0152_28229-oExhJ8.jpeg https://medicaex.com/businesswire/charles-river-laboratories-opens-contract-vivarium-space-in-chicago-enhancing-access-to-aaalac-accredited-turnkey-research-program/ 2022-11-28T13:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/charles_river_logo-skrz5p.jpeg https://medicaex.com/businesswire/exscientia-receives-first-cta-approval-to-initiate-ignite-ai-a-phase-1-2-trial-of-exs-21546-in-patients-with-advanced-solid-tumours-3/ 2022-11-28T12:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/Exscientia_Logo-kmhTWJ.jpeg https://medicaex.com/businesswire/ani-pharmaceuticals-announces-the-fda-approval-and-launch-of-fluoxetine-oral-solution-usp-2/ 2022-11-28T12:12:15+00:00 https://medicaex.com/businesswire/exscientia-receives-first-cta-approval-to-initiate-ignite-ai-a-phase-1-2-trial-of-exs-21546-in-patients-with-advanced-solid-tumours-2/ 2022-11-28T12:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/Exscientia_Logo-I5Qdhi.jpeg https://medicaex.com/businesswire/ge-healthcare-and-ulrich-medical-announce-an-agreement-to-offer-a-branded-multi-dose-contrast-media-injector-in-the-u-s-3/ 2022-11-28T12:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/GE_Healthcare_branded_CT_Motion_injector-fR3MMI.jpeg https://medicaex.com/businesswire/ge-healthcare-and-ulrich-medical-announce-an-agreement-to-offer-a-branded-multi-dose-contrast-media-injector-in-the-u-s-2/ 2022-11-28T12:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/GE_Healthcare_branded_CT_Motion_injector-FD1Q8i.jpeg https://medicaex.com/businesswire/2022-bladder-cancer-update-bulletin-key-opinion-leader-kol-views-on-recent-developments-researchandmarkets-com/ 2022-11-28T12:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-puGevo.jpeg https://medicaex.com/businesswire/exscientia-receives-first-cta-approval-to-initiate-ignite-ai-a-phase-1-2-trial-of-exs-21546-in-patients-with-advanced-solid-tumours/ 2022-11-28T12:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/Exscientia_Logo-XJEIf5.jpeg https://medicaex.com/businesswire/ani-pharmaceuticals-announces-the-fda-approval-and-launch-of-fluoxetine-oral-solution-usp/ 2022-11-28T12:12:06+00:00 https://medicaex.com/businesswire/ge-healthcare-and-ulrich-medical-announce-an-agreement-to-offer-a-branded-multi-dose-contrast-media-injector-in-the-u-s/ 2022-11-28T12:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/GE_Healthcare_branded_CT_Motion_injector-J5PyrO.jpeg https://medicaex.com/businesswire/asia-pacific-electrocardiograph-market-report-to-2031-players-include-abbott-laboratories-acs-diagnostics-biotricity-and-edan-instruments-among-others-researchandmarkets-com/ 2022-11-28T10:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-GYxzmT.jpeg https://medicaex.com/businesswire/high-potency-apis-market-analysis-report-2022-therapeutic-application-type-of-synthesis-type-of-manufacturers-global-forecast-to-2029-researchandmarkets-com/ 2022-11-28T10:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-TDsyYV.jpeg https://medicaex.com/businesswire/gflow-neural-networks-to-help-accelerate-molecules-and-candidates-generation-experts-say-2/ 2022-11-28T09:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/06-mrL3hw.jpeg https://medicaex.com/businesswire/gflow-neural-networks-to-help-accelerate-molecules-and-candidates-generation-experts-say/ 2022-11-28T09:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/06-yljkpX.jpeg https://medicaex.com/businesswire/almirall-joins-facilitate-a-patient-driven-innovative-medicines-initiative-imi-project-to-enable-the-use-of-clinical-trial-data-by-study-participants-2/ 2022-11-28T08:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/Almirall_HQ_in_Barcelona-df9bvd.jpeg https://medicaex.com/businesswire/global-diabetes-insulin-delivery-pen-market-2022-insights-trends-competition-growth-opportunities-market-size-market-share-data-analysis-outlook-and-forecasts-2015-2021-2022-2028-resea-2/ 2022-11-28T08:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-3BRiS0.jpeg https://medicaex.com/businesswire/global-diabetes-insulin-delivery-pen-market-2022-insights-trends-competition-growth-opportunities-market-size-market-share-data-analysis-outlook-and-forecasts-2015-2021-2022-2028-resea/ 2022-11-28T08:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-bCuyk6.jpeg https://medicaex.com/businesswire/almirall-joins-facilitate-a-patient-driven-innovative-medicines-initiative-imi-project-to-enable-the-use-of-clinical-trial-data-by-study-participants/ 2022-11-28T08:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/Almirall_HQ_in_Barcelona-mQIWi1.jpeg https://medicaex.com/businesswire/ferinject-approved-in-chinafor-the-treatment-of-iron-deficiency-in-adult-patients-3/ 2022-11-28T06:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/CSLVifor_RGB_Highres_M01-JxfPTI.jpeg https://medicaex.com/businesswire/ferinject-approved-in-chinafor-the-treatment-of-iron-deficiency-in-adult-patients/ 2022-11-28T06:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/CSLVifor_RGB_Highres_M01-52yrGZ.jpeg https://medicaex.com/businesswire/escient-pharmaceuticals-announces-120-million-series-c-financing-2/ 2022-11-28T05:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/Escient_Logo_28white_background29-hy2sFa.jpeg https://medicaex.com/businesswire/escient-pharmaceuticals-announces-120-million-series-c-financing/ 2022-11-28T05:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/Escient_Logo_28white_background29-7H0mad.jpeg https://medicaex.com/businesswire/2022-chungbuk-best-product-promotion-opens-in-singapore-to-develop-market-for-promising-export-companies-in-chungcheongbuk-do-province/ 2022-11-28T01:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo_edt-tmWDxN.jpeg https://medicaex.com/businesswire/biocytogen-enters-into-antibody-agreement-with-adc-therapeutics-2/ 2022-11-28T00:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/LOGO-9eyP4N.jpeg https://medicaex.com/businesswire/biocytogen-enters-into-antibody-agreement-with-adc-therapeutics/ 2022-11-28T00:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/LOGO-lGNQyR.jpeg https://medicaex.com/businesswire/ge-healthcare-introduces-signa-experience-a-new-platform-of-transformative-technologies-that-leverage-the-power-of-ai-and-deep-learning-in-mri-scanning-2/ 2022-11-27T17:12:09+00:00 https://medicaex.com/businesswire/ge-healthcare-introduces-signa-experience-a-new-platform-of-transformative-technologies-that-leverage-the-power-of-ai-and-deep-learning-in-mri-scanning/ 2022-11-27T17:12:06+00:00 https://medicaex.com/businesswire/ge-healthcare-highlights-transformative-precision-innovations-and-collaborations-that-help-drive-the-future-of-health/ 2022-11-27T14:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/ge_monogram_primary_gray_cool-gray-10-pMbVL5.jpeg https://medicaex.com/businesswire/henry-schein-announces-lineup-of-new-products-software-and-equipment-at-the-greater-new-york-dental-meeting/ 2022-11-26T12:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/HenrySchein_2000x374-cjkRQb.jpeg https://medicaex.com/businesswire/cameron-jacox-joins-dawn-health-the-leading-insomnia-digital-health-clinic-as-strategic-advisor-2/ 2022-11-26T04:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/Screen_Shot_2022-09-19_at_7.20.51_PM-V2JqtJ.jpeg https://medicaex.com/businesswire/cameron-jacox-joins-dawn-health-the-leading-insomnia-digital-health-clinic-as-strategic-advisor/ 2022-11-26T04:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/Screen_Shot_2022-09-19_at_7.20.51_PM-T2q07S.jpeg https://medicaex.com/businesswire/agex-therapeutics-receives-extension-of-time-to-attain-compliance-with-stock-exchange-continued-listing-requirements-2/ 2022-11-25T21:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/AGEX_logo_400x400-I4dERZ.jpeg https://medicaex.com/businesswire/imv-receives-nasdaq-notification-regarding-market-value-of-listed-securities-2/ 2022-11-25T21:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/IMV_Logos_IMV-Logo_Primary-iHMbNu.jpeg https://medicaex.com/businesswire/agex-therapeutics-receives-extension-of-time-to-attain-compliance-with-stock-exchange-continued-listing-requirements/ 2022-11-25T21:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/AGEX_logo_400x400-TTTNpI.jpeg https://medicaex.com/businesswire/imv-receives-nasdaq-notification-regarding-market-value-of-listed-securities/ 2022-11-25T21:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/IMV_Logos_IMV-Logo_Primary-yKT54V.jpeg https://medicaex.com/businesswire/global-antimicrobial-additives-market-report-2022-to-2027-industry-trends-share-size-growth-opportunities-and-forecasts-researchandmarkets-com/ 2022-11-25T18:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-ecxOge.jpeg https://medicaex.com/businesswire/global-medical-billing-outsourcing-market-report-2022-to-2027-industry-trends-share-size-growth-opportunities-and-forecasts-researchandmarkets-com-2/ 2022-11-25T18:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-41iCtT.jpeg https://medicaex.com/businesswire/global-medical-billing-outsourcing-market-report-2022-to-2027-industry-trends-share-size-growth-opportunities-and-forecasts-researchandmarkets-com/ 2022-11-25T18:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-VFOeNk.jpeg https://medicaex.com/businesswire/elispot-and-fluorospot-assay-market-report-2022-use-of-fluorospot-assays-for-multiple-analyte-detection-in-single-well-presents-opportunities-researchandmarkets-com-4/ 2022-11-25T17:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-Xw65T1.jpeg